Single Cell Gescheft @WeizmannScience
Joined November 2017
- Tweets 6,190
- Following 490
- Followers 17,321
- Likes 8,257
1,018 Photos and videos
Pinned Tweet
Jan 22
What if we could turn the tumorโs deadliest tricks against it?
New @Cancer_Cell: Tumor-antigen-independent targeting of solid tumors by armored macrophage-directed anti-TREM2 CAR T cells. Led by @GalYagel, @D_Rimini & @MVLocquenghien (1/15)
cell.com/cancer-cell/abstracโฆ
17
34
96
12,630
Jun 8
If you want to do great and creative science with the most AMAZING PI, this is the place to go!! ๐ฅ๐คฉ
hello world.
Excited to launch the Ingelfinger Lab account! Weโre a young lab in Germanyโs Black Forest tackling key questions in immunology with innovative single-cell technologies.
Follow us for updates on systems immunology, machine learning & translational oncology.
fi
1
2
21
7,395
Jun 2
๐Christmas came early this year!๐
We have an additional 50 places available at this year's #SCG2026 taking place from September 16th-18th in beautiful Dunblane, Scotland
Full details and registration link ๐๐ผ
conferences.weizmann.ac.il/Sโฆ
Abstract deadline is in two weeks (June 15th)
2
9
2,049
May 31
The dark side of macrophages:
Macrophage plasticity is one of biologyโs greatest strengths. And one of its greatest risks.
cell.com/cell/abstract/S0092โฆ
43
198
13,040
May 29
For those of you who think macrophages do almost everything, rethink โalmost.โ
They are programmable cells, recruited into whatever new function evolution needs.
science.org/doi/10.1126/scieโฆ
4
68
290
72,008
May 22
Celebrating Shavuot with our annual lab cooking competition! This yearโs dishes made the competition especially tough, with creativity and flavor at every table. Wishing our friends around the world a joyful holiday!
1
30
2,944
May 20
Absolute joy hosting the one and only @jonykipnis to discuss the frontiers of neuroimmunology and how we can translate these discoveries into next-generation immunotherapies.
1
4
45
11,184
May 1
Beautiful work Marco and co. congratulations!
What defines human pDC diversity? Our newest work led by @UlezkoAlina in @ImmunityCP uncovers a complex landscape shaped by age and tissue niche, including a cycling pDC subset that declines with age but persists in the BM & expands in malignant BPDCN. shorturl.at/99Zui
8
2,869
May 1
Fantastic new study by @Brown_lab1, @MiriamMerad and teams: mRNA vaccine potency comes from detargeting hepatocytes, not dendritic cell expression, avoiding PD1/PDL1-driven T cell suppression. A path to better, more effective therapies. nature.com/articles/s41587-0โฆ
9
46
4,326
May 1
ืขืืื ืืืฉ ืืืืช.
ืืืืงืจ ืืื ืืื ืืืฉื ืืืื ืืืืกื ืืืจืคืืื ืืืฉืจืืืืช, ืืืฆืื ืืช ืืฉืจืื ืืืืืช ืืขืืืืืช ืฉื ืืืคืืื CAR-T ืืืืืืช ืืืืืืืืื ืืืช.
ืฉืืคื ืืืื ืืคืจืืคโ ืืืืื ืืืจ, ืคืจืืคโ ืคืืืื ื ืกืืคื ืกืงื ืืโืจ ืฉืืื ืืืืืก ืขื ืืืืื ืืืืฆื ืืืืฉื ืืช ืฉื ืชืืื ืขื ืคืืื ืฆืืื ืืฉื ืืช ืืช ืืื ืืืืืคืืื ืื ืืืกืื.
Apr 30
ืืืคืื ืืืืืืช ืืืืืืืืื ืืืช ืืืืฆืขืืช car. ืืืื ืฉืจืืื ืคืื ืื ื ืืืืจ: ืื ืื ื ืืืืื ืืืคืืื ื CAR-T ืืืืืื ืขื ืืืืืช ืืืืืืืื ืืืช. ื ืืื, ืื ืืฉืื ืืงืกืคืจืืื ืืื ืืื ืืคืื ื ืืืจ ืืืขื 10 ืืืืื ืขื ืชืืฆืืืช ืืฆืืื ืืช !
ืืฉ ืืืืืจ ืืื ืืช ืืืชืืืืื ืืื ืืืืคืื ืืืื ืืืจ ืืืขืื (ืืฆืื ื ืืืืืจืืคื) ืืืืื ืฉื ืฉื ืชืืื ืฉืืืฉ (ืขื ืื) ืืืืคืืก, ืืืืืืืืก, ืกืงืืจืืืจืื, apla, ืืขืื.
ืขืืื ืืืฉ. ืืืืคืื ืืื ืืขื ืืงืจืื ืืืจื ื resetting ืฉื ืืืขืจืืช ืืืืืื ืืช, ืืืื ืชืงืืืชื ื ืืจืืคืื! ืืื ืจืง ืืคืืื ืืืคืืืช ืืืง ืืืืืืื. ืขืืื ืืืฉ. ืืื ืืฉ ืืืจืืจ ืืช ืืืืืคืืื ืืืชืืืืื.
1
2
17
2,952
Apr 28
#SCG2026 registration opens at 1 PM UK time on Thursday, 30 April. Spots are limited, and in previous years registration filled in less time than it takes to run a UMAP. Register here:
conferences.weizmann.ac.il/Sโฆ
13
2,521
Apr 24
Beautiful work @garber_manuel and co. Immunology is magical!
nature.com/articles/s41590-0โฆ
16
78
7,701
Apr 14
Congratulations Dr. Von Locquenghien @MVLocquenghien for successfully defending your PhD thesis! ๐
5
38
2,640
Apr 1
This is what real progress against cancer looks like: immunotherapy exploiting tumor vulnerabilities one after another. Now itโs time to extend that progress to many more tumor types!
Mar 31
How outcomes in relapsed/refractory multiple myeloma changed, from 1986 to 2026
1
6
33
4,719
Mar 29
Celebrating amazing discoveries, innovation, and the people who make it all possible. #Unstoppable
5
57
3,799
Mar 19
Beautiful and important work from Aaron, colleagues, and the Adimab team. If we are still missing such a basic property of therapeutic antibodies, imagine how much of Ab mechanism of action we still do not fully understand, and how much more could be achieved if we did.
Mar 17
How specific are therapeutic monoclonal antibodies, really?
In our new paper, @Yile_Dai led a collaboration with Adimab to profile 174 FDA-approved and clinical-stage mAbs against 6,172 human extracellular proteins.
What we found surprised us.๐งต
sciencedirect.com/science/arโฆ
2
12
3,178
Mar 9
Thank you @CancerCell for featuring our cover! ๐ Inspired by honeybee โsocial immunityโ where colonies detect and manage sick nestmates, we engineered TME-regulated armored TREM2 CAR T cells to unmask and dismantle immunosuppressive niches in solid tumors @GalYagel @D_Rimini
1
12
31
2,460
Mar 4
Thank you @lai9uan and @FGinhoux for highlighting our reaserch!
Congratulations for the new Vita journal and team!
Mar 4
Our commentary in #Vita journal with @FGinhoux
highlights an elegant study from the @IdoAmitLab @CellCellPress , a clever design for immunocytokines that selectively activate within tumors - linking myeloid reprogramming to trigger maximum response.
Link: shorturl.at/GXPJO
2
16
3,011
Feb 25
Fantastic meeting and lineup, looking forward!
Feb 24
Join us at Cell Symposia: Single-Cell Biology in the Era of AI (Dec 2โ4, 2026, Munich) ๐ฉ๐ช
From multi-omics to AI-driven models of cellular dynamics โ an exciting lineup across experimental & computational biology.
Hope to see you there!
๐ cell-symposia.com/single-celโฆ
7
2,349